Wedbush Morgan initiates coverage on Alexza Pharmaceuticals (Nasdaq: ALXA) with a Buy. Price target $12.

Wedbush analyst says, "Q4/FY EPS ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE